New York, NY -- (SBWIRE) -- 12/11/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Hanwha Solarone Co Ltd (NASDAQ:HSOL), Galena Biopharma Inc (NASDAQ:GALE), Titan Pharmaceuticals, Inc (OTCBB:TTNP), General Motors Company (NYSE:GM)
Hanwha Solarone Co Ltd (NASDAQ:HSOL) showed a volume of 2.29 million shares by the end of last trade whereas the average volume of the stock remained 2.03 million shares. The stock opened the session at $2.64 but then moved to $2.79. At that price, the stock showed a positive performance of 4.49%. Hanwha SolarOne Co., Ltd. (Hanwha SolarOne) is an integrated manufacturer of silicon ingots, silicon wafers, PV cells and PV modules in China. The Company manufactures a range of silicon ingots, silicon wafers, Photovoltaic (PV) cells and PV modules using advanced manufacturing process technologies that have helped the Company to increase its operational efficiency.
Will HSOL Continue To Move Higher? Find Out Here
Galena Biopharma Inc (NASDAQ:GALE) opened the session at $4.25 and closed the session at $3.97. The stock showed a negative performance of -7.48% in previous trading session. Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics. The Company is pursuing the development of cancer therapeutics using peptide-based immunotherapy products, including its main product candidate, NeuVaxTM (E75), for the treatment of breast cancer and other tumors.
Has GALE Found The Bottom And Ready To Gain Momentum? Find Out Here
Titan Pharmaceuticals, Inc (OTCBB:TTNP) opened the session at $0.72 and closed the session at $0.820. The stock showed a positive performance of 17.14% in previous trading session. Traded with volume of 602,646.00 shares in the prior session and the average volume of the stock remained 254,792.00 shares. The beta of the stock remained 10.87. Titan Pharmaceuticals, Inc. is a biopharmaceutical company developing proprietary therapeutics primarily for the treatment of central nervous system (CNS) disorders. The Company is focused primarily on clinical development of the following products: Probuphine for the treatment of opioid addiction; Iloperidone: for the treatment of schizophrenia and related psychotic disorders; and Spheramine for the treatment of advanced Parkinson’s disease.
Why Should Investors Buy TTNP After The Recent Gain? Just Go Here and Find Out
General Motors Company (NYSE:GM) the stock advanced 1.22% and finished the session at $40.40. Traded with volume of 32.54 million shares in the prior session and the average volume of the stock remained 24.95 million shares. The beta of the stock remained 1.68. General Motors Corporation (General Motors) designs, build and sell cars, trucks and automobiles parts globally. The Company also provides automotive financing services through General Motors Financial Company, Inc. (GM Financial). The Company's automotive operations meet the demands of the Company's customers through its four automotive segments: GM North America (GMNA), GM Europe (GME), GM International Operations (GMIO) and GM South America (GMSA).
Will GM Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)